Role of Aldehyde Dehydrogenase 2 in 1-Methy-4-Phenylpyridinium Ion-Induced Aldehyde Stress and Cytotoxicity in PC12 Cells

[1]  H. Nakayama,et al.  Involvement of monoamine oxidase-B in the acute neurotoxicity of MPTP in embryonic and newborn mice. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[2]  T. Schäffer,et al.  Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity , 2013, Molecular and Cellular Neuroscience.

[3]  S. Donnini,et al.  Mitochondrial aldehyde dehydrogenase-2 activation prevents &bgr;-amyloid-induced endothelial cell dysfunction and restores angiogenesis , 2013, Journal of Cell Science.

[4]  Jing Wang,et al.  Mechanisms of MPP+-induced PC12 cell apoptosis via reactive oxygen species , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[5]  B. Ritz,et al.  Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease , 2012, Proceedings of the National Academy of Sciences.

[6]  Yun Chai,et al.  Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? , 2012, Biochemical and biophysical research communications.

[7]  D. Kong,et al.  Modulation of Aldehyde Dehydrogenase Activity Affects (±)-4-Hydroxy-2E-nonenal (HNE) Toxicity and HNE–Protein Adduct Levels in PC12 Cells , 2012, Journal of Molecular Neuroscience.

[8]  B. Liu,et al.  Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. , 2012, European journal of pharmacology.

[9]  J. Rodríguez-Zavala,et al.  Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts. , 2012, Chemical research in toxicology.

[10]  D. Goldstein,et al.  Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease , 2012, PloS one.

[11]  Ashutosh Kumar Singh,et al.  Short-term exposure of 4-hydroxynonenal induces mitochondria-mediated apoptosis in PC12 cells , 2012, Human & experimental toxicology.

[12]  M. Das,et al.  Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade , 2011, Journal of Neuroinflammation.

[13]  J. Pedraza-Chaverri,et al.  S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. , 2011, The Journal of nutritional biochemistry.

[14]  J. Doorn,et al.  Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease. , 2011, Chemico-biological interactions.

[15]  Y. Hsieh,et al.  MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  K. Lee,et al.  Kaempferol Attenuates 4-Hydroxynonenal-Induced Apoptosis in PC12 Cells by Directly Inhibiting NADPH Oxidase , 2011, Journal of Pharmacology and Experimental Therapeutics.

[17]  Jun Ren,et al.  Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. , 2011, European heart journal.

[18]  Xiao-Qing Tang,et al.  Inhibition of Hydrogen Sulfide Generation Contributes to 1-Methy-4-Phenylpyridinium Ion-Induced Neurotoxicity , 2011, Neurotoxicity Research.

[19]  A. A. Farooqui,et al.  Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease , 2011, Parkinson's disease.

[20]  Jing Zhao,et al.  Neuroprotective effect of asymmetric dimethylarginine against 1‐methyl‐4‐phenylpyridinium ion‐induced damage in PC12 cells , 2010, Clinical and experimental pharmacology & physiology.

[21]  Xudong Xu,et al.  D-β-Hydroxybutyrate Prevents MPP+-Induced Neurotoxicity in PC12 Cells , 2010, Neurochemical Research.

[22]  M. Yin,et al.  Antioxidative and anti-inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. , 2009, Journal of food science.

[23]  M. Disatnik,et al.  Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart , 2008, Science.

[24]  Z. Qin,et al.  Differential effects of overexpression of wild-type and mutant human α-synuclein on MPP+-induced neurotoxicity in PC12 cells , 2008, Neuroscience Letters.

[25]  G. Aldini,et al.  Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls , 2007, Medicinal research reviews.

[26]  E. Ellis.  Reactive carbonyls and oxidative stress: potential for therapeutic intervention. , 2007, Pharmacology & therapeutics.

[27]  Y. Shang,et al.  Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathway , 2007, Apoptosis.

[28]  P. Wood,et al.  The concept of “aldehyde load” in neurodegenerative mechanisms: Cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line , 2007, Brain Research.

[29]  D. D. Di Monte,et al.  Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation* , 2007, Journal of Biological Chemistry.

[30]  S. Shimohama,et al.  Proteasome Inhibition Induces Glutathione Synthesis and Protects Cells from Oxidative Stress , 2007, Journal of Biological Chemistry.

[31]  D. Conklin,et al.  Aldehyde metabolism in the cardiovascular system. , 2007, Molecular bioSystems.

[32]  P. Wood.  Neurodegeneration and aldehyde load: from concept to therapeutics. , 2006, Journal of psychiatry & neuroscience : JPN.

[33]  P. Wood,et al.  Neurotoxicity of reactive aldehydes: The concept of “aldehyde load” as demonstrated by neuroprotection with hydroxylamines , 2006, Brain Research.

[34]  N. Wood,et al.  Expanding insights of mitochondrial dysfunction in Parkinson's disease , 2006, Nature Reviews Neuroscience.

[35]  Vasilis Vasiliou,et al.  Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family , 2005, Human Genomics.

[36]  M. Vila,et al.  MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease , 2004, Journal of bioenergetics and biomembranes.

[37]  S. Ohta,et al.  Mitochondrial ALDH2 Deficiency as an Oxidative Stress , 2004, Annals of the New York Academy of Sciences.

[38]  V. Vasiliou,et al.  Role of Human Aldehyde Dehydrogenases in Endobiotic and Xenobiotic Metabolism , 2004, Drug metabolism reviews.

[39]  D. S. Zahm,et al.  3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s disease pathogenesis , 2003, Brain Research.

[40]  K. Nishimaki,et al.  Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells , 2003, Journal of neurochemistry.

[41]  Ted M. Dawson,et al.  Neuroprotective and neurorestorative strategies for Parkinson's disease , 2002, Nature Neuroscience.

[42]  B. Halliwell,et al.  Proteasomal dysfunction induced by 4‐hydroxy‐2,3‐trans‐nonenal, an end‐product of lipid peroxidation: a mechanism contributing to neurodegeneration? , 2002, Journal of neurochemistry.

[43]  W. Keung.  Biogenic aldehyde(s) derived from the action of monoamine oxidase may mediate the antidipsotropic effect of daidzin. , 2001, Chemico-biological interactions.

[44]  K. Uchida.  Role of reactive aldehyde in cardiovascular diseases. , 2000, Free radical biology & medicine.

[45]  M. Selley.  (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. , 1998, Free radical biology & medicine.

[46]  K. S. Yoon,et al.  Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats , 1998, Neuroscience Letters.

[47]  N. Hattori,et al.  Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Strong,et al.  An endogenous dopaminergic neurotoxin: implication for Parkinson's disease. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[49]  E. Cadenas,et al.  Redox cycling of MPP+: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase. , 1993, Free radical biology & medicine.

[50]  B. Vallee,et al.  Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Chiueh,et al.  Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals , 2009, Neurotoxicity Research.

[52]  D. D. Di Monte,et al.  Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. , 2007, The Journal of biological chemistry.